BIOCQ — Biocept Cashflow Statement
0.000.00%
- $0.00m
- -$4.46m
- $25.86m
Annual cashflow statement for Biocept, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -24.6 | -25.1 | -17.8 | -2.82 | -32.1 |
Depreciation | |||||
Non-Cash Items | 0.614 | 2.56 | 3.2 | 5.54 | 3.86 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.801 | -1.4 | -6.27 | -0.552 | 13.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -22.4 | -23 | -19.8 | 3.69 | -13.3 |
Capital Expenditures | -0.145 | -0.735 | -0.867 | -1.57 | -0.807 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.145 | -0.735 | -0.867 | -1.57 | -0.807 |
Financing Cash Flow Items | 0 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 23.8 | 29.7 | 25.7 | 12.4 | -1.87 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.28 | 5.88 | 5.07 | 14.5 | -16 |